one8zero8 LLC’s Rocket Pharmaceuticals RCKT Stock Holding History

one8zero8 LLC’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-39,700	Closed	-$499K	–	272
2024 Q4	$499K	Buy	+39,700	New	+$598K	0.11%	143

Other funds holding RCKT

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

one8zero8 LLC's RCKT Position: Q1 2025 in Review

one8zero8 LLC sold out of Rocket Pharmaceuticals (RCKT) in Q1 2025, closing a stake of 39,700 shares — an estimated $499K sold.

one8zero8 LLC first reported a position in RCKT in Q4 2024 and held it in 1 quarter. The position peaked at $499K in Q4 2024. 236 funds tracked by Wall St. Rank hold RCKT as of Q1 2025.

one8zero8 LLC reported no remaining Rocket Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
one8zero8 LLC sold 39,700 Rocket Pharmaceuticals shares in Q1 2025, an estimated $499K.
one8zero8 LLC first reported a position in Rocket Pharmaceuticals in Q4 2024 and held it in 1 quarter.
one8zero8 LLC's Rocket Pharmaceuticals position peaked at $499K in Q4 2024.
236 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2025.

Based on one8zero8 LLC's 13F filing for Q1 2025, filed 7 May 2025.